Newsletter Says Sell China Sky One Medical (CSKI)
More News related to CSKI
- China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits
- China Sky One Medical (CSKI) Posts Q3 EPS of $0.74, Tops Views by 8c
- China Sky One Medical, Inc. Announces Record Third Quarter 2009 Results
- Trading Radar for 11/17: Home Depot (HD), Saks (SKS), Target (TGT), Autodesk (ADSK), La-Z-Boy (LZB) Report
- Semi-Annual Changes to the NASDAQ Biotechnology Index
More News related to Insiders' Blog
- Hemispherx (HEB) Shares Breaking Out as $1 Technical Level Holds; Stock Up 23%
- Activision's (ATVI) Call of Duty Amasses $3 Billion in Global Sales
- Casino Stocks Tumble Sharply Amid Dubai Concerns (MGM, LVS, WYNN)
- Dubai Fallout ETF Trades
- Apple (AAPL) Shares to Open Below $200 as Dubai World Debt Weighs on Stocks
The Asia Edge newsletter is now recommending investors Sell China Sky One Medical (NASDAQ: CSKI), after first recommending investors to Buy the stock in mid-August.
The newsletter writer Robert Hsu said after meetings with the founder and CEO Yan-Qing Liu, they strongly believe the company needs to improve its internal control and corporate governance. The newsletter notes CKSI once hired a 26-year-old graduate student as a director on its board. It was only after investors found out about this that the company replaced him with a former management consultant from McKinsey & Co.. Hsu says,
Related Categories
Insiders' BlogTrader Talk
Stocks Mentioned
-0.39Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
